FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

16239811000001104: ReQuip 250microgram tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57230901000001112 ReQuip 250microgram tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57231001000001115 ReQuip 250microgram tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
ReQuip 250microgram tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) Is a Product containing precisely ropinirole (as ropinirole hydrochloride) 250 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) Has active ingredient Ropinirole hydrochloride false Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) Has specific active ingredient Ropinirole hydrochloride true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ropinirole true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) Is a ReQuip true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
ReQuip 250microgram tablets (Lexon (UK) Ltd) Has basis of strength substance Ropinirole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
ReQuip 250microgram tablets (Lexon (UK) Ltd) 21 tablet Has AMP True ReQuip 250microgram tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start